Sign In
3 Aug 2021 11:12
Ap24
Ā
FORMĀ 38.5(a)
Ā
IRISHĀ TAKEOVERĀ PANEL
Ā
DISCLOSUREĀ UNDERĀ RULEĀ 38.5(a)Ā OFĀ THEĀ IRISHĀ TAKEOVERĀ PANEL ACT,Ā 1997,Ā TAKEOVERĀ RULES,Ā 2013
Ā
DEALINGSĀ BYĀ CONNECTEDĀ EXEMPTĀ PRINCIPALĀ TRADERSĀ WITHĀ RECOGNISEDĀ INTERMEDIARYĀ STATUSĀ ANDĀ DEALINGĀ INĀ AĀ CLIENT-SERVINGĀ CAPACITY
Ā
1. KEYĀ INFORMATION
Ā
Name of exempt principal trader | J.P. Morgan Securities Plc |
Company dealt in | UDG Healthcare Plc |
Class of relevant security to which the dealings being disclosed relate (Note 1) | ā¬0.05 ordinary shares |
Date of dealing | 2 August 2021 |
Ā
2. DEALINGSĀ (NoteĀ 2)
Ā
(a) PurchasesĀ andĀ sales
Ā
Total number of relevant securities acquired | Highest price paid (Note 3) | Lowest price paid (Note 3) |
285,973 | 10.7831 GBP | 10.7700 GBP |
Ā
Ā
Total number of securities disposed | Highest price received (Note 3) | Lowest price received (Note 3) |
164,197 | 10.7850 GBP | 10.7635 GBP |
Ā
Ā
(b) DerivativesĀ transactionsĀ (otherĀ thanĀ optionsĀ transactions)
Ā
Product name, e.g. CFD | Nature of transaction (Note 4) | Number of relevant securities (Note 5) | Price per unit (Note 3) |
Equity Swap | Decrease Long Ā Ā Decrease Short Ā Ā Ā Ā Ā Increase Long Ā Ā Ā Ā Ā Ā Increase Short Ā Ā Ā Ā Opening a Long Position Ā Ā Ā Ā Ā Ā Ā Ā Opening a Short Position Ā Ā Ā Ā | 9,501 12,318 Ā 4,103 149 1,024 6,663 19,928 Ā 89 13,475 13,869 14 3,230 18 Ā 11,632 3,000 660 44,931 Ā 9,021 9,021 6,509 9,848 3,170 1,121 328 14,629 Ā 3,886 2,932 27,431 729 18,669 | 10.7753 GBP 10.7794 GBP Ā 10.7635 GBP 10.7696 GBP 10.7703 GBP 10.7725 GBP 10.7791 GBP Ā 10.7398 GBP 10.7719 GBP 10.7744 GBP 10.7750 GBP 10.7774 GBP 10.7798 GBP Ā 10.7709 GBP 10.7770 GBP 10.7804 GBP 10.7831 GBP Ā 10.7691 GBP 10.7694 GBP 10.7698 GBP 10.7700 GBP 10.7750 GBP 10.7795 GBP 10.7797 GBP 10.7800 GBP Ā 10.7701 GBP 10.7751 GBP 10.7800 GBP 10.7801 GBP 10.7805 GBP |
Ā
Ap25
Ā
(c) OptionsĀ transactionsĀ inĀ respectĀ ofĀ existingĀ relevantĀ securities
Ā
Ā
(i) Writing,Ā selling,Ā purchasingĀ orĀ varying
Ā
Product name, e.g. call option | Writing, selling, purchasing, varying etc. | Number of securities to which the option relates (Note 5) | Exercise price | Type, e.g. American, European etc. | Expiry date | Option money paid/received per unit (Note 3) |
Ā | Ā | Ā | Ā | Ā | Ā | Ā |
Ā
Ā
(ii) Exercising
Ā
Product name, e.g. call option | Number of securities | Exercise price per unit (Note 3) |
Ā | Ā | Ā |
Ā
Ā
3. Ā OTHERĀ INFORMATION
Ā
Agreements,Ā arrangementsĀ orĀ understandingsĀ relatingĀ toĀ optionsĀ orĀ derivatives
Ā
FullĀ detailsĀ ofĀ anyĀ agreement,Ā arrangementĀ orĀ understandingĀ betweenĀ theĀ person disclosingĀ andĀ
anyĀ otherĀ personĀ relatingĀ toĀ theĀ votingĀ rightsĀ ofĀ anyĀ relevantĀ securitiesĀ underĀ anyĀ optionĀ referredĀ toĀ
onĀ thisĀ formĀ orĀ relatingĀ toĀ theĀ votingĀ rightsĀ orĀ futureĀ acquisitionĀ orĀ disposalĀ ofĀ anyĀ relevantĀ securitiesĀ toĀ
whichĀ anyĀ derivative referredĀ toĀ onĀ thisĀ formĀ isĀ referenced.Ā IfĀ none,Ā thisĀ shouldĀ beĀ stated.
Ā
Ā
Ā
Ā
Ā
Ā
Date of disclosure | 3 August 2021 |
Contact name | Alwyn Basch |
Telephone number | 020 7742 7407 |
Name of offeree/offeror with which connected | UDG Healthcare Plc |
Nature of connection (Note 6) | Financial adviser to CD&R Fund XI |
Ā
Follow the stocks
